Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $428049.00.
ENTERPRISE VALUE (EV)
$428049.00
Alaunos Therapeutics, Inc.
Market Cap
$1.81M
Enterprise Value (EV)
$428049.00
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | $1.81M | $428049.00 |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | $15.12M |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | N/A |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | $5.85M |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | N/A |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | N/A |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | N/A |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | $12.50M |
Market Cap
$1.81M
Total Debt
$0.00
Cash
$1.39M
Enterprise Value
$428049.00
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
